• #ECFS2018 – Disparities in CF Care Across Europe Focus of ECFS Meeting in Belgrade
  • #ECRD2018 – EU Must Do More for Rare Disease Patients, Eurordis Leaders Say
  • ‘Rare Impact Awards’ Dinner Marks Orphan Drug Act and NORD at 35
  • Long-term Kalydeco Treatment Improves Clinical Outcomes in Cystic Fibrosis Patients, Study Shows
  • 26 Years and Counting with CF
  • Once-daily Tobramycin Safe to Treat Flares in Children Under Age 6, Study Says
  • CF Battered Me, but I’m Striking Back at Life at a Full Sprint
  • Gastrointestinal Cancers More Common in Adults with CF, Especially After Transplant, Study Finds
  • Rally Cycling Team Using Custom Bikes Inspired by Children to Benefit UHCCF
  • Proteostasis Appoints 7 CF Experts to Guide Design of PTI-428 Phase 3 Program
  • Vertex’s CFTR Modulators Too Costly, ICER Panel Says; Vertex Disagrees
  • CF Canada Launches Campaign to Make Orkambi Accessible to More Patients